State Street’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
Other funds holding BVS
EWM
JIC
NCM
RA
State Street's BVS Position: Q2 2026 in Review
State Street increased its Bioventus (BVS) stake by 12% in Q2 2026, buying an estimated $1.11M and bringing the position to 1,104,878 shares worth $10.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2686.
State Street first reported a position in BVS in Q1 2021 and has held it in 22 quarters since. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.
- State Street held 1,104,878 shares of Bioventus worth $10.4M as of Q2 2026.
- State Street bought 116,511 Bioventus shares in Q2 2026, an estimated $1.11M.
- Bioventus made up ﹤0.01% of State Street's portfolio in Q2 2026, its #2686 holding.
- State Street first reported a position in Bioventus in Q1 2021 and has held it in 22 quarters since.
- 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.